BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32626713)

  • 1. Structural and Functional Insight Into the Glycosylation Impact Upon the HGF/c-Met Signaling Pathway.
    Hu X; Tang F; Liu P; Zhong T; Yuan F; He Q; von Itzstein M; Li H; Weng L; Yu X
    Front Cell Dev Biol; 2020; 8():490. PubMed ID: 32626713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy.
    Liu X; Sun R; Chen J; Liu L; Cui X; Shen S; Cui G; Ren Z; Yu Z
    Front Cell Dev Biol; 2020; 8():23. PubMed ID: 32083078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of HGF/MET axis in resistance of lung cancer to contemporary management.
    Raghav KP; Gonzalez-Angulo AM; Blumenschein GR
    Transl Lung Cancer Res; 2012 Sep; 1(3):179-93. PubMed ID: 25806180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers.
    Zhang H; Feng Q; Chen WD; Wang YD
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer.
    Miranda O; Farooqui M; Siegfried JM
    Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30134579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF/c-MET targeted therapeutics: novel strategies for cancer medicine.
    Yap TA; Sandhu SK; Alam SM; de Bono JS
    Curr Drug Targets; 2011 Dec; 12(14):2045-58. PubMed ID: 21777195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment.
    Hartmann S; Bhola NE; Grandis JR
    Clin Cancer Res; 2016 Aug; 22(16):4005-13. PubMed ID: 27370607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
    Ilangumaran S; Villalobos-Hernandez A; Bobbala D; Ramanathan S
    Cytokine; 2016 Jun; 82():125-39. PubMed ID: 26822708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals.
    Kato T
    Biomed Rep; 2017 Dec; 7(6):495-503. PubMed ID: 29188052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma.
    Wang H; Rao B; Lou J; Li J; Liu Z; Li A; Cui G; Ren Z; Yu Z
    Front Cell Dev Biol; 2020; 8():55. PubMed ID: 32117981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasion-Metastasis by Hepatocyte Growth Factor/c-Met Signaling Concomitant with Induction of Urokinase Plasminogen Activator in Human Pancreatic Cancer: Role as Therapeutic Target.
    Lee KH; Hyun MS; Kim JR
    Cancer Res Treat; 2003 Jun; 35(3):207-12. PubMed ID: 26680937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HGF/MET signaling in ovarian cancer.
    Zhou HY; Pon YL; Wong AS
    Curr Mol Med; 2008 Sep; 8(6):469-80. PubMed ID: 18781954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of HGF/c-MET signaling pathway in lymphoma.
    Lam BQ; Dai L; Qin Z
    J Hematol Oncol; 2016 Dec; 9(1):135. PubMed ID: 27923392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism study of HGF/c-MET pathway activation and immune regulation for a tumor diagnosis model.
    Shen Z; Xue W; Zheng Y; Geng Q; Wang L; Fan Z; Wang W; Yue Y; Zhai Y; Li L; Zhao J
    Cancer Cell Int; 2021 Jul; 21(1):374. PubMed ID: 34261467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment.
    Rothenberger NJ; Stabile LP
    Cancers (Basel); 2017 Apr; 9(4):. PubMed ID: 28441771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGF/c-Met Axis: The Advanced Development in Digestive System Cancer.
    Shao Z; Pan H; Tu S; Zhang J; Yan S; Shao A
    Front Cell Dev Biol; 2020; 8():801. PubMed ID: 33195182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression.
    Noriega-Guerra H; Freitas VM
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Potential Mechanism of Tumor Progression during Systemic Infections Via the Hepatocyte Growth Factor (HGF)/c-Met Signaling Pathway.
    Tsujimoto H; Horiguchi H; Matsumoto Y; Takahata R; Shinomiya N; Yamori T; Miyazaki H; Ono S; Saitoh D; Kishi Y; Ueno H
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32630328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor.
    Fukuta K; Matsumoto K; Nakamura T
    Biochem J; 2005 Jun; 388(Pt 2):555-62. PubMed ID: 15693751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
    Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.